UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044591
Receipt number R000050651
Scientific Title The study for identifying the antigen of culprit agents of perioperative anaphylaxis
Date of disclosure of the study information 2021/06/18
Last modified on 2021/06/18 17:31:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study for identifying the antigen of culprit agents of perioperative anaphylaxis

Acronym

The study for identifying the antigen of culprit agents of perioperative anaphylaxis

Scientific Title

The study for identifying the antigen of culprit agents of perioperative anaphylaxis

Scientific Title:Acronym

The study for identifying the antigen of culprit agents of perioperative anaphylaxis

Region

Japan


Condition

Condition

Anaphylaxis

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Identify the antigenic site of the causative agent in patients with anaphylaxis

Basic objectives2

Others

Basic objectives -Others

Diagnosis

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Basophil activation tests conducted 4 to 6 weeks after anaphylaxis

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Blood sampling

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Those who have had anaphylaxis during the perioperative period

Key exclusion criteria

Those who the doctor deems inappropriate for participating in this study

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Tomonori
Middle name
Last name Takazawa

Organization

Gunma University Hospital

Division name

Intensive Care Unit

Zip code

371-8511

Address

3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511

TEL

027-220-8454

Email

takazawt@gunma-u.ac.jp


Public contact

Name of contact person

1st name Kazuhiro
Middle name
Last name Nagumo

Organization

Gunma University Hospital

Division name

Department of Anesthesiology

Zip code

371-8511

Address

3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511

TEL

027-220-8454

Homepage URL


Email

m1920023@gunma-u.ac.jp


Sponsor or person

Institute

Gunma University Hospital, Department of Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University Hospital, Department of Anesthesiology

Address

3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511

Tel

027-220-8454

Email

m1920023@gunma-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 05 Month 20 Day

Date of IRB


Anticipated trial start date

2021 Year 06 Month 03 Day

Last follow-up date

2036 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 06 Month 18 Day

Last modified on

2021 Year 06 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050651


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name